D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.14% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 10.3% |
| 4 | Financials | 9.14% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WIN
2351
DELISTED
Windstream Holdings Inc
WIN
| $1.59M | ﹤0.01% |
302,353
+146,801
| +94% | +$1.03M |
|
2352
Aptevo Therapeutics
APVO
$4.96M
| – | – |
0
| – | – |
|
2353
PUT
Kimberly-Clark
KMB
$37.6B
| $1.58M | ﹤0.01% |
+15,000
| New | +$1.56M |
|
2354
Prestige Consumer Healthcare
PBH
$2.47B
| $1.58M | ﹤0.01% |
+41,085
| New | +$1.39M |
|
2355
CALL
Johnson Controls International
JCI
$85.1B
| $1.57M | ﹤0.01% |
+47,000
| New | +$1.63M |
|
2356
Columbia Banking Systems
COLB
$8.71B
| $1.57M | ﹤0.01% |
38,382
-36,298
| -49% | -$1.55M |
|
|
HMHC
2357
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.57M | ﹤0.01% |
205,222
+16,134
| +9% | +$115K |
|
2358
BioMarin Pharmaceuticals
BMRN
$11.9B
| $1.57M | ﹤0.01% |
16,644
-69,066
| -81% | -$6.05M |
|
|
KE
2359
Kimball Electronics
KE
$564M
| $1.57M | ﹤0.01% |
85,553
+10,017
| +13% | +$179K |
|
2360
Toyota
TM
$228B
| $1.56M | ﹤0.01% |
12,145
-6,753
| -36% | -$890K |
|
|
PE
2361
PUT
DELISTED
PARSLEY ENERGY INC
PE
| $1.56M | ﹤0.01% |
51,500
| – | – |
|
2362
Lennar Class B
LEN.B
$19.9B
| $1.56M | ﹤0.01% |
38,403
+4,253
| +12% | +$176K |
|
2363
Alliant Energy
LNT
$18.6B
| $1.55M | ﹤0.01% |
+36,648
| New | +$1.51M |
|
2364
PUT
GameStop
GME
$9.8B
| $1.55M | ﹤0.01% |
425,600
-49,200
| -10% | -$169K |
|
2365
Arrowhead Research
ARWR
$12.1B
| $1.55M | ﹤0.01% |
113,909
-777,875
| -87% | -$7.27M |
|
2366
Hamilton Lane
HLNE
$3.88B
| $1.55M | ﹤0.01% |
32,295
+17,643
| +120% | +$776K |
|
|
SCHW
2367
CALL
Charles Schwab
SCHW
$182B
| $1.55M | ﹤0.01% |
+30,300
| New | +$1.68M |
|
2368
Watts Water Technologies
WTS
$11.2B
| $1.55M | ﹤0.01% |
19,738
+7,013
| +55% | +$544K |
|
|
OXFD
2369
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.55M | ﹤0.01% |
120,058
+95,222
| +383% | +$1.29M |
|
2370
PUT
Fabrinet
FN
$14.9B
| $1.55M | ﹤0.01% |
41,900
-6,200
| -13% | -$212K |
|
2371
Biglari Holdings Class A
BH.A
$1.2B
| $1.54M | ﹤0.01% |
+1,624
| New | +$1.62M |
|
|
EBIX
2372
DELISTED
Ebix Inc
EBIX
| $1.54M | ﹤0.01% |
20,195
-6,531
| -24% | -$501K |
|
|
GPOR
2373
PUT
DELISTED
Gulfport Energy Corp.
GPOR
| $1.54M | ﹤0.01% |
122,400
| – | – |
|
2374
America's Car Mart
CRMT
$25.9M
| $1.54M | ﹤0.01% |
+24,850
| New | +$1.43M |
|
2375
Coherus Oncology
CHRS
$217M
| $1.53M | ﹤0.01% |
109,183
+94,042
| +621% | +$1.35M |
|
Similar funds
D.E. Shaw & Co's Q2 2018 Portfolio in Review
As of Q2 2018, D.E. Shaw & Co held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- D.E. Shaw & Co added most to Amazon in Q2 2018, an estimated $696M increase.
- D.E. Shaw & Co's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- D.E. Shaw & Co fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- D.E. Shaw & Co opened 622 new positions and closed 399 in Q2 2018.
- D.E. Shaw & Co's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.